In Macquarie Infrastructure Corp. v. Moab Partners, L.P., the Supreme Court held that an issuerβs nondisclosure of information required by Item 303 of Regulation S-K cannot support a cl...
On March 25, 2024, a Ninth Circuit panel affirmed the dismissal of a putative securities class action alleging that a biopharmaceutical company misled the public in May 2020 about the dev...
On October 11, 2023, a Ninth Circuit panel dismissed for lack of jurisdiction an appeal from the dismissal of a putative securities class action. The appellant was an investor who filed ...
More shareholder challenges of offshore corporate transactions are likely to be filed in U.S. courts following a recent decision holding that a forum clause in a foreign issuerβs deposi...
A Second Circuit panel affirmed a decision dismissing securities fraud claims against Danske Bank and its officers and directors. The panel unanimously held that plaintiffs had not pled ...
On April 12, 2019, the United States Court of Appeals for the Second Circuit held that the district court abused its discretion by failing to consider a forum selection clause in a foreig...
The first quarter of 2018 saw continued significant securities-suit filing activity against life sciences companies with more than 10 actions filed, including several filed by some of the...
On March 20, 2018, the Supreme Court decided Cyan, Inc. v. Beaver County Employees Retirement Fund (βCyanβ), ruling unanimously that, under the Securities Litigation Uniform Standards...
On January 31, 2018, the United States Court of Appeals for the Ninth Circuit issued an opinion in Mineworkerβ Pension Scheme v. First Solar Inc., No. 15-17282 (9th Cir. Jan. 31, 2018)....
As part of a series of regular updates on developments in life sciences securities litigation (see Q3 2017 Quarterly Report), this report addresses recent activity in securities actions a...
